Allison Dorval, Director of Puma Biotechnology PBYI, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $83.6K. The latest trade was on 06/12.

AD

AD

Allison Dorval

Director

Company

Puma Biotechnology PBYI

First filing

23/02/16

Trades

32 trades

Buys / sales

0 / 7

12-month net buying

−$83.6K

Last trade

06/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Puma BiotechnologyPBYI	Open-market sale10b5-1 plan	06/12	06/15	11,610 sh	$7.20	$83,592	−11.3%
Puma BiotechnologyPBYI	Open-market sale10b5-1 plan	25/06/13	25/06/17	11,610 sh	$3.40	$39,474	−13.3%
VT Verve Therapeutics	Open-market sale10b5-1 plan	25/04/02	25/04/03	3,350 sh	$4.15	$13,902.5	−20.1%
VT Verve Therapeutics	Open-market sale	24/12/02	24/12/03	555 sh	$5.64	$3,130.2	−9.4%
Puma BiotechnologyPBYI	Open-market sale10b5-1 plan	24/06/13	24/06/17	11,000 sh	$3.37	$37,070	−25.0%
VT Verve Therapeutics	Open-market sale	23/11/29	23/12/01	554 sh	$11.45	$6,343.3	−12.0%
Puma BiotechnologyPBYI	Open-market sale10b5-1 plan	23/06/13	23/06/15	10,000 sh	$3.45	$34,500	−37.0%